Integra LifeSciences ( NASDAQ:IART – Get Free Report ) was downgraded by equities research analysts at StockNews.com from a 'buy' rating to a 'hold' rating in a research report issued on Friday. Several other equities analysts have also recently commented on IART. Truist Financial lifted their target price on shares of Integra LifeSciences from $44.00 to $48.00 in a research report on Wednesday, July 19th. JPMorgan Chase & Co. lowered Integra LifeSciences from a 'neutral' rating to an 'underweight' rating and decreased their target price for the company from $56.

https://www.dailypolitical.com/2023/08/06/integra-lifesciences-nasdaqiart-stock-rating-lowered-by-stocknews-com.html

#dailypolitical